The immune reaction during ischemia opens new doors for advanced targeted therapeutics. Nowadays stem cell therapy has shown better results in stroke-prone individuals. Few monoclonal antibodies like natalizumab have shown a great impact on pre-clinical and clinical stroke trial studies 1).

Chavda V, Madhwani K, Chaurasia B. Stroke and Immunotherapy: Potential Mechanisms and its implications as immune-therapeutics. Eur J Neurosci. 2021 Apr 7. doi: 10.1111/ejn.15224. Epub ahead of print. PMID: 33829590.
  • immunotherapy.txt
  • Last modified: 2023/05/03 11:06
  • by administrador